Fluopsin C for Treating Multidrug-Resistant Infections: In vitro Activity Against Clinically Important Strains and in vivo Efficacy Against Carbapenemase-Producing Klebsiella pneumoniae

The increasing emergence of multidrug-resistant (MDR) organisms in hospital infections is causing a global public health crisis. The development of drugs with effective antibiotic action against such agents is of the highest priority. In the present study, the action of Fluopsin C against MDR clinic...

Descripción completa

Detalles Bibliográficos
Autores principales: Navarro, Miguel Octavio Pérez, Simionato, Ane Stefano, Pérez, Juan Carlos Bedoya, Barazetti, André Riedi, Emiliano, Janaina, Niekawa, Erika Tyemi Goya, Andreata, Matheus Felipe de Lima, Modolon, Fluvio, Dealis, Mickely Liuti, Araújo, Eduardo José de Almeida, Carlos, Thalita Massi, Scarpelim, Odair José, da Silva, Denise Brentan, Chryssafidis, Andreas Lazaros, Bruheim, Per, Andrade, Galdino
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6824035/
https://www.ncbi.nlm.nih.gov/pubmed/31708901
http://dx.doi.org/10.3389/fmicb.2019.02431

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6824035/
https://www.ncbi.nlm.nih.gov/pubmed/31708901
http://dx.doi.org/10.3389/fmicb.2019.02431

Ejemplares similares